A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panel

Por Wu, Yi-Long, Wang, Chang-Li, Sun, Yan, Liao, Mei-Lin, Guan, Zhong-Zhen, Yang, Zhi-Min, Zhou, Qing-Hua, Lu, Shun, Cheng, Ying, Liu, Xiao-Qing, Zhang, Xu-Chao, Zhou, Caicun, Wang, Jie, Zhou, Qing, Song, Yong, Han, Bao-Hui, Ma, Zhi-Yong, Yang, Fan, Wang, Qun, Chuai, Shao-Kun, Shao, Yang, He, Wei, Zhu, Guanshan, Xiong, Lei, Wang, Jian-Jun, Chen, Ke-Neng, Zhang, Li, Mao, Wei-Min, Ma, Sheng-Lin, Feng, Ji-Feng, Yang, Xue-Ning, Xu, Lin, Chen, Gang, Zhao, Jian, Song, Qi-Bin, SHEN-TU, Yang, Qiao, Gui-Bin, Yu, Ding, Yu, Shi-Ying, Hu, Yi, Chen, Ming, Chen, Gong-Yan, Fan, Yun, Zhang, He-Long, Liang, Jun, Zhu, Guang-Ying, Cui, Jiu-Wei, Yang, Jin-Ji, Zhao, Qiong, Zhao, Ming-Fang, Lu, You, Chang, Jian-Hua, Li, Jun-Ling, Yang, Yue, Hu, Jie, Gu, Chun-Dong, Zhang, Yi-Chen, Zhong, Wen-Zhao
Publicado no ESMO Open (2017)

Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma

Por Patil, Vijay Maruti, Noronha, Vanita, Joshi, Amit, Choughule, Anuradha Bharat, Bhattacharjee, Atanu, Kumar, Rajiv, Goud, Supriya, More, Sucheta, Ramaswamy, Anant, Karpe, Ashay, Pande, Nikhil, Chandrasekharan, Arun, Goel, Alok, Talreja, Vikas, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Publicado no ESMO Open (2017)

The European Society for Medical Oncology Magnitude of Clinical Benefit Scale in daily practice: a single institution, real-life experience at the Medical University of Vienna

Por Kiesewetter, Barbara, Raderer, Markus, Steger, Günther G, Bartsch, Rupert, Pirker, Robert, Zöchbauer-Müller, Sabine, Prager, Gerald, Krainer, Michael, Preusser, Matthias, Schmidinger, Manuela, Zielinski, Christoph C
Publicado no ESMO Open (2016)

Phase I study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX PI)

Por Satake, Hironaga, Miki, Akira, Kondo, Masato, Kotake, Takeshi, Okita, Yoshihiro, Hatachi, Yukimasa, Yasui, Hisateru, Imai, Yukihiro, Ichikawa, Chihiro, Murotani, Kenta, Hashida, Hiroki, Kobayashi, Hiroyuki, Kotaka, Masahito, Kato, Takeshi, Kaihara, Satoshi, Tsuji, Akihito
Publicado no ESMO Open (2017)

Recent developments and translational aspects in targeted therapy for metastatic breast cancer

Por Marhold, Maximilian, Bartsch, Rupert, Zielinski, Christoph
Publicado no ESMO Open (2016)

KRAS-driven lung adenocarcinoma: combined DDR1/Notch inhibition as an effective therapy

Por Ambrogio, Chiara, Nadal, Ernest, Villanueva, Alberto, Gómez-López, Gonzalo, Cash, Timothy P, Barbacid, Mariano, Santamaría, David
Publicado no ESMO Open (2016)

CECOG educational illustrations: the blood–brain barrier and its relevance for targeted cancer therapies and immuno-oncology

Por Preusser, Matthias, Berghoff, Anna S, Thallinger, Christiane, Zielinski, Christoph
Publicado no ESMO Open (2017)

Health-related quality of life in a randomised phase III study of gemcitabine plus S-1, S-1 alone and gemcitabine alone for locally advanced or metastatic pancreatic cancer: GEST s...

Por Hagiwara, Yasuhiro, Ohashi, Yasuo, Okusaka, Takuji, Ueno, Hideki, Ioka, Tatsuya, Boku, Narikazu, Egawa, Shinichi, Hatori, Takashi, Furuse, Junji, Mizumoto, Kazuhiro, Ohkawa, Shinichi, Yamaguchi, Taketo, Yamao, Kenji, Funakoshi, Akihiro, Cheng, Ann-Lii, Kihara, Kiyohiro, Sato, Atsushi, Tanaka, Masao
Publicado no ESMO Open (2017)

Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate

Por Ree, Anne Hansen, Russnes, Hege G, Heinrich, Daniel, Dueland, Svein, Boye, Kjetil, Nygaard, Vigdis, Silwal-Pandit, Laxmi, Østrup, Olga, Hovig, Eivind, Nygaard, Vegard, Rødland, Einar A, Nakken, Sigve, Øien, Janne T, Johansen, Christin, Bergheim, Inger R, Skarpeteig, Veronica, Sathermugathevan, Menaka, Sauer, Torill, Lund-Iversen, Marius, Beiske, Klaus, Nasser, Salah, Julsrud, Lars, Reisse, Claudius H, Ruud, Espen A, Flørenes, Vivi Ann, Hagene, Kirsten T, Aas, Eline, Lurås, Hilde, Johnsen-Soriano, Siv, Geitvik, Gry A, Lingjærde, Ole Christian, Børresen-Dale, Anne-Lise, Mælandsmo, Gunhild M, Flatmark, Kjersti
Publicado no ESMO Open (2017)

The European Cancer Patient’s Bill of Rights, update and implementation 2016

Por Højgaard, Liselotte, Löwenberg, Bob, Selby, Peter, Lawler, Mark, Banks, Ian, Law, Kate, Albreht, Tit, Armand, Jean-Pierre, Barbacid, Mariano, Barzach, Michèle, Bergh, Jonas, Cameron, David, Conte, Pierfranco, de Braud, Filippo, de Gramont, Aimery, De Lorenzo, Francesco, Diehl, Volker, Diler, Sarper, Erdem, Sema, Geissler, Jan, Gore-Booth, Jola, Henning, Geoffrey, Horgan, Denis, Jassem, Jacek, Johnson, Peter, Kaasa, Stein, Kapitein, Peter, Karjalainen, Sakari, Kelly, Joan, Kienesberger, Anita, La Vecchia, Carlo, Lacombe, Denis, Lindahl, Tomas, Luzzatto, Lucio, Malby, Rebecca, Mastris, Ken, Meunier, Françoise, Murphy, Martin, Naredi, Peter, Nurse, Paul, Oliver, Kathy, Pearce, Jonathan, Pelouchov, Jana, Piccart, Martine, Pinedo, Bob, Spurrier-Bernard, Gilly, Sullivan, Richard, Tabernero, Josep, Van de Velde, Cornelis, van Herk, Bert, Vedsted, Peter, Waldmann, Anita, Weller, David, Wilking, Nils, Wilson, Roger, Yared, Wendy, Zielinski, Christoph, zur Hausen, Harald, Le Chevalier, Thierry, Johnston, Patrick
Publicado no ESMO Open (2017)

Switching from standard to dose-dense chemotherapy in front-line treatment of advanced ovarian cancer: a retrospective study of feasibility and efficacy

Por Milani, Andrea, Kristeleit, Rebecca, McCormack, Mary, Raja, Fharat, Luvero, Daniela, Widschwendter, Martin, MacDonald, Nicola, Mould, Tim, Olatain, Adeola, Hackshaw, Allan, Ledermann, Jonathan A
Publicado no ESMO Open (2017)

Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group

Por Stacchiotti, S., Gronchi, A., Fossati, P., Akiyama, T., Alapetite, C., Baumann, M., Blay, J. Y., Bolle, S., Boriani, S., Bruzzi, P., Capanna, R., Caraceni, A., Casadei, R., Colia, V., Debus, J., Delaney, T., Desai, A., Dileo, P., Dijkstra, S., Doglietto, F., Flanagan, A., Froelich, S., Gardner, P. A., Gelderblom, H., Gokaslan, Z. L., Haas, R., Heery, C., Hindi, N., Hohenberger, P., Hornicek, F., Imai, R., Jeys, L., Jones, R. L., Kasper, B., Kawai, A., Krengli, M., Leithner, A., Logowska, I., Martin Broto, J., Mazzatenta, D., Morosi, C., Nicolai, P., Norum, O. J., Patel, S., Penel, N., Picci, P., Pilotti, S., Radaelli, S., Ricchini, F., Rutkowski, P., Scheipl, S., Sen, C., Tamborini, E., Thornton, K. A., Timmermann, B., Torri, V., Tunn, P. U., Uhl, M., Yamada, Y., Weber, D. C., Vanel, D., Varga, P. P., Vleggeert-Lankamp, C. L. A., Casali, P. G., Sommer, J.
Publicado no Ann Oncol (2017)

Cancer and liver cirrhosis: implications on prognosis and management

Por Pinter, Matthias, Trauner, Michael, Peck-Radosavljevic, Markus, Sieghart, Wolfgang
Publicado no ESMO Open (2016)

Update on clinical research and state of the art management of patients with advanced sarcomas and GIST

Por Metaxas, Yannis, Oikonomopoulos, Georgios, Pentheroudakis, George
Publicado no ESMO Open (2016)

Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial...

Por Ricotta, Riccardo, Verrioli, Antonella, Ghezzi, Silvia, Porcu, Luca, Grothey, A, Falcone, Alfredo, Van Cutsem, Eric, Argilés, Guillem, Adenis, Antoine, Ychou, Marc, Barone, Carlo, Bouché, Olivier, Peeters, Marc, Humblet, Yves, Mineur, Laurent, Sobrero, Alberto F, Hubbard, Joleen M, Cremolini, Chiara, Prenen, Hans, Tabernero, Josep, Jarraya, Hajer, Mazard, Thibault, Deguelte-Lardiere, Sophie, Papadimitriou, Konstantinos, Van den Eynde, Marc, Pastorino, Alessandro, Redaelli, Daniela, Bencardino, Katia, Funaioli, Chiara, Amatu, Alessio, Carlo-Stella, Giulia, Torri, Valter, Sartore-Bianchi, Andrea, Vanzulli, Angelo, Siena, Salvatore
Publicado no ESMO Open (2017)

Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 200...

Por Davis, Courtney, Naci, Huseyin, Gurpinar, Evrim, Poplavska, Elita, Pinto, Ashlyn, Aggarwal, Ajay
Publicado no BMJ (2017)

Predictive and prognostic biomarkers of targeted agents and modern immunotherapy in renal cell carcinoma

Por Rodriguez-Vida, Alejo, Strijbos, Michiel, Hutson, Thomas
Publicado no ESMO Open (2016)

Cancer genome: highlights of a Nature Medicine perspective

Por Voest, Emile
Publicado no ESMO Open (2016)

Immune checkpoint blockade in small cell lung cancer: is there a light at the end of the tunnel?

Por Paglialunga, Luca, Salih, Zena, Ricciuti, Biagio, Califano, Raffaele
Publicado no ESMO Open (2016)

Recent advances in the biology of human circulating tumour cells and metastasis

Por Gkountela, Sofia, Szczerba, Barbara, Donato, Cinzia, Aceto, Nicola
Publicado no ESMO Open (2016)